PCa Active Surveillance Safe, Effective for Younger Patients
A majority of active surveillance patients under age 60 did not progress to definitive prostate cancer treatment.
A majority of active surveillance patients under age 60 did not progress to definitive prostate cancer treatment.
Targeting PI-RADS 4 and 5 lesions for confirmatory biopsy improves detection of clinically significant cancer.
Median overall survival was 9.3 months longer for black versus white patients with metastatic castration-resistant prostate cancer.
Lowest quartile of serum testosterone is associated with 48% and 65% increased odds of stress and mixed urinary incontinence, respectively.
Fusion biopsy has improved over the last decade and increasingly detects clinically significant prostate cancer, according to data trends from one institution.
Average International Prostate Symptom Score remained low 5 years after the PVP laser procedure.
Researchers identified a predictor of new-onset UI after HoLEP that may aid urologists in clinical practice.
In a study, 81.1% of men were able to void after an average of 28 days after treatment.
Highest quartile of alkaline phosphatase velocity in men who experience biochemical recurrence after radical prostatectomy is associated with 2-fold higher risk.
Systematic biopsy parameters identified patients at higher risk of positive surgical margins.